XML 9 R2.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Income Statements - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Total revenue $ 1,242.0 $ 983.0 $ 3,430.0 $ 2,766.0
Cost of sales (30.0) (28.0) (89.0) (93.0)
Gross profit (loss) 1,212.0 955.0 3,341.0 2,673.0
Research and development (737.0) (533.0) (2,078.0) (1,525.0)
Selling, general and administrative (284.0) (247.0) (795.0) (727.0)
Disposal, restructuring and other operating expenses, net (6.0) 0.0 (6.0) 0.0
Total operating expense (1,027.0) (780.0) (2,879.0) (2,252.0)
Operating income (loss) 185.0 175.0 462.0 421.0
Income (loss) from equity investments, net 6.0 39.0 (6.0) 53.0
Interest income, net 29.0 28.0 83.0 89.0
Other non-operating income (loss), net 8.0 26.0 137.0 13.0
Income (loss) before income taxes 228.0 268.0 676.0 576.0
Income tax benefit (expense) (5.0) (16.0) (85.0) 6.0
Net income (loss) $ 223.0 $ 252.0 $ 591.0 $ 582.0
Net income (loss) per share attributable to ordinary shareholders        
Basic (in dollars per share) $ 0.21 $ 0.24 $ 0.56 $ 0.56
Diluted (in dollars per share) $ 0.21 $ 0.24 $ 0.55 $ 0.55
Weighted average ordinary shares outstanding        
Basic (in shares) 1,062 1,052 1,060 1,049
Diluted (in shares) 1,069 1,064 1,068 1,062
External Customers        
Total revenue $ 904.0 $ 698.0 $ 2,342.0 $ 2,165.0
Related Party        
Total revenue $ 338.0 $ 285.0 $ 1,088.0 $ 601.0